Expression and function of the K+ channel KCNQ genes in human arteries. - Wikidata - awgldk - TriplyDB

Expression and function of the K+ channel KCNQ genes in human arteries.

Expression and function of the K+ channel KCNQ genes in human arteries.

http://www.wikidata.org/entity/Q34449702

about

Neuronal and Cardiovascular Potassium Channels as Therapeutic Drug Targets: Promise and Pitfalls Ion channel remodeling in vascular smooth muscle during hypertension: Implications for novel therapeutic approaches Driving with no brakes: molecular pathophysiology of Kv7 potassium channels N-Pyridyl and Pyrimidine Benzamides as KCNQ2/Q3 Potassium Channel Openers for the Treatment of Epilepsy Differential activation of vascular smooth muscle Kv7.4, Kv7.5, and Kv7.4/7.5 channels by ML213 and ICA-069673.Kv7 and Kv11 channels in myometrial regulation.Vasorelaxant effects of novel Kv 7.4 channel enhancers ML213 and NS15370 Fundamental role for the KCNE4 ancillary subunit in Kv7.4 regulation of arterial tone.Molecular expression and pharmacological evidence for a functional role of kv7 channel subtypes in Guinea pig urinary bladder smooth muscle Functional and molecular evidence for Kv7 channel subtypes in human detrusor from patients with and without bladder outflow obstruction.Chemical control of metabolically-engineered voltage-gated K+ channels.KV7 channels regulate muscle tone and nonadrenergic noncholinergic relaxation of the rat gastric fundus.Heterogeneity in Kv7 channel function in the cerebral and coronary circulation.G-protein βγ subunits are positive regulators of Kv7.4 and native vascular Kv7 channel activity.Molecular microdomains in a sensory terminal, the vestibular calyx ending Kv7 potassium channels in airway smooth muscle cells: signal transduction intermediates and pharmacological targets for bronchodilator therapy.The Novel KV7.2/KV7.3 Channel Opener ICA-069673 Reveals Subtype-Specific Functional Roles in Guinea Pig Detrusor Smooth Muscle Excitability and Contractility Clinical utility, safety, and tolerability of ezogabine (retigabine) in the treatment of epilepsy.Pharmacological dissection of K(v)7.1 channels in systemic and pulmonary arteries.Resident phenotypically modulated vascular smooth muscle cells in healthy human arteries.Novel Roles for Kv7 Channels in Shaping Histamine-Induced Contractions and Bradykinin-Dependent Relaxations in Pig Coronary Arteries.One man's side effect is another man's therapeutic opportunity: targeting Kv7 channels in smooth muscle disorders.Kv7.5 Potassium Channel Subunits Are the Primary Targets for PKA-Dependent Enhancement of Vascular Smooth Muscle Kv7 Currents.Potent vasorelaxant activity of the TMEM16A inhibitor T16A(inh) -A01 Translational value of mechanical and vasomotor properties of mouse isolated mesenteric resistance-sized arteries.Effective contractile response to voltage-gated Na+ channels revealed by a channel activator.Modulation of K(v)7 potassium channels by a novel opener pyrazolo[1,5-a]pyrimidin-7(4H)-one compound QO-58 KV7 channels contribute to paracrine, but not metabolic or ischemic, regulation of coronary vascular reactivity in swine Functional Expression Profile of Voltage-Gated K(+) Channel Subunits in Rat Small Mesenteric Arteries.Potassium channels in peripheral pain pathways: expression, function and therapeutic potential.KV 7 channels are involved in hypoxia-induced vasodilatation of porcine coronary arteries.Differential protein kinase C-dependent modulation of Kv7.4 and Kv7.5 subunits of vascular Kv7 channels.Role of vascular potassium channels in the regulation of renal hemodynamics.The KCNE Tango - How KCNE1 Interacts with Kv7.1.KCNQ Potassium Channels Modulate Sensitivity of Skin Down-hair (D-hair) Mechanoreceptors.Modulation of Kv7 channels and excitability in the brain.Facilitation of sympathetic neurotransmission by phosphatidylinositol-4,5-bisphosphate-dependent regulation of KCNQ channels in rat mesenteric arteries.MicroRNA-153 targeting of KCNQ4 contributes to vascular dysfunction in hypertension.Vascular KCNQ channels in humans: the sub-threshold brake that regulates vascular tone?Cardiovascular responses to retigabine in conscious rats--under normotensive and hypertensive conditions

P2860

Q26798018-7FE243D3-9C93-42A1-8E39-CBDA2CD1769A Q26996048-6B71983F-3F85-4C3B-B18D-C60F8F63F3A0 Q27023978-31494338-0A6E-4774-AE58-BD840860CF93 Q30040856-FED2596A-4BD3-4E5B-B7BC-105C6490B7DB Q34125218-A3000D5E-FA94-4411-A061-53CB2252D65B Q34193194-A78488D1-ADDD-442A-BA5A-013D110C06C0 Q34402797-4D1A4778-4D78-4EB4-A1ED-F8CDE705EC07 Q34499486-86BD0D10-2C53-48C7-ACE1-23232AC49FA0 Q35000941-24509878-AC34-4334-B986-925AF52E6D6B Q35098568-282A462C-D623-4B6E-90DA-1583DE5191B2 Q35165386-BD168ABB-4253-4255-A547-2189D26C46C5 Q35228397-309D356C-A735-4F77-A5A4-8971D1D93E55 Q35538269-0B2F058E-9E47-473B-8FFA-EA54BFE1BC58 Q35644862-0F622D20-19E1-4369-B739-D740F3D3C43E Q35748331-DC3E7D4D-5262-49C6-9770-923BB6A1BC76 Q35950205-5DAAA61D-08B4-4174-ABE8-4509C2935C7F Q35962040-D0E13692-1E4F-452A-909F-DEA62E8F1873 Q36144410-A5AA019F-7690-46B6-A2CB-131CEBAE7B78 Q36159058-07C68252-B58D-4075-A0CC-078D2E65A064 Q36382192-E9352D15-AE04-419D-893D-EA594A1365CD Q36546867-F6768C0B-642E-4071-B0E0-4C3ECB18705B Q36603168-F67401D1-F97F-4DA9-B31D-20B40055F857 Q36618785-72AE5067-9BFE-49D2-B39A-8564AAB83395 Q36629310-BBE4CDB9-A58F-4340-8974-AD4D1BE6E749 Q36648857-65EA1BBD-8774-461F-85A0-4C416306643C Q36764117-79ACC310-8C71-4620-AEE2-06856AAB2978 Q36781082-450E0FBE-F0A0-492F-A665-8A460F3CADC4 Q36895771-43AF73EF-A1D4-4F8B-989A-D4CE7AA3EF6E Q36998626-1E284EF9-DCF6-48D7-A07A-38D512ABB47A Q37362041-73EE740C-C034-40FF-8935-1FBD70658132 Q37418220-BE4060F4-F0F5-4516-AFF6-6229B1971BAC Q37511713-B9D18E54-6A80-4A07-99D6-4547AA4653EB Q37968360-A73952CB-56D2-482E-AAF9-23DDB257892C Q38033161-26F5B0B0-3E41-40A5-B053-ADE2BB49C6B4 Q38915867-0BA7B435-2217-4782-936C-485250C96C95 Q38958968-B0153703-3C6D-42A1-876E-40445C3D8DB0 Q39347205-41850673-CBEE-4CA9-A3B1-CC9F7E097F08 Q41166517-DEE97A8B-05E7-4B39-9D5A-E999D906CDDD Q41538933-8047AB90-3E8D-406B-9FB5-1C92E320D57D Q41771260-DDDCC367-FC59-48D0-BE1A-262A1B80ACD0

P2860

Expression and function of the K+ channel KCNQ genes in human arteries.

http://www.wikidata.org/entity/Q34449702

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Expression and function of the K+ channel KCNQ genes in human arteries.

@ast

Expression and function of the K+ channel KCNQ genes in human arteries.

@en

Expression and function of the K+ channel KCNQ genes in human arteries.

@nl

type

label

Expression and function of the K+ channel KCNQ genes in human arteries.

@ast

Expression and function of the K+ channel KCNQ genes in human arteries.

@en

Expression and function of the K+ channel KCNQ genes in human arteries.

@nl

prefLabel

Expression and function of the K+ channel KCNQ genes in human arteries.

@ast

Expression and function of the K+ channel KCNQ genes in human arteries.

@en

Expression and function of the K+ channel KCNQ genes in human arteries.

@nl

P1433

Q34449702-405E9C7E-6CBC-44B9-9CBF-91E71752CDA7

P1476

Q34449702-0A1CD156-424E-453F-83AC-2521E4FEC3C7

P2093

Q34449702-0F7690D6-4A4A-4621-80B5-DBC77770D295

Q34449702-26D32722-4AD8-4567-959E-0EF63028EFF0

Q34449702-5B46F5BB-9F19-4C1E-B0B4-068E645DD1D1

Q34449702-68E79244-AAAD-4692-9D8B-0E4CB42B1322

Q34449702-7EAADDE0-F6EA-4615-A27E-8DAB0A8D9836

Q34449702-8E39D16F-AAE2-449C-97A1-75E657101723

Q34449702-FA1A15FC-2862-4979-BC02-6BC4D78FDCD0

Q34449702-FDB76530-97B9-46C4-8679-52BF68791576

P2860

Q34449702-03768726-F507-47A8-99D9-9262670D1285

Q34449702-08828111-BC1B-4A82-ACAE-5ECC4C2EEFD8

Q34449702-1531DD15-9625-495B-99BA-A42FE6EC53B9

Q34449702-190B251C-4920-4EBE-AF05-53444EB82655

Q34449702-1BE3E36F-9D92-49D2-A80E-996C365D8F7F

Q34449702-1D8CAA56-976F-4A83-A0A7-836AD853FFE1

Q34449702-1E034E98-EF8D-4740-BAD2-59A1E51BDC29

Q34449702-41412782-D5F7-4881-A1BF-792E40A51A05

Q34449702-415C3D7F-4953-4122-A0D0-1F0068000F75

Q34449702-450CA0A1-ED5D-44D6-A12B-B7F147C9C49E

P304

Q34449702-6DAB40F1-E5ED-4869-BB74-C03839FEBC2E

P31

Q34449702-A19D15E7-C10B-4CEA-A7C2-EF68B4F0D54A

P356

Q34449702-0B5122B2-CE3D-44AF-9091-6916547F5DB4

P407

Q34449702-C078C1E3-6E1A-438D-9D48-7C9323E4A9EB

P433

Q34449702-AB37C3D5-47AF-4689-929D-2D1D0BBAAFC5

P478

Q34449702-8407759B-082F-4624-8E90-E6E2F0FD6BF8

P50

Q34449702-0F59A5EE-9C3E-4B1D-864B-20B710A34A43

Q34449702-BA680773-87A9-4619-9F52-2C2703E58AD5

Q34449702-d626dab8-49e9-2d10-271f-317825b7dc1b

P577

Q34449702-0935F9B1-E822-4743-9619-6ED968EC61F9

P5875

Q34449702-537D2DD8-4BB4-4028-A1F9-4F28D528CA72

P698

Q34449702-761616C9-8809-4909-80F4-490991AC1067

P932

Q34449702-8DFBC0AD-E4E7-4E1A-B876-A1BF170B4FD2

P356

J.1476-5381.2010.01027.X

P1433

British Journal of Pharmacology

P1476

Expression and function of the K+ channel KCNQ genes in human arteries

@en

P2093

Alison J Davis

http://www.w3.org/2001/XMLSchema#string

Antonio Nardi

http://www.w3.org/2001/XMLSchema#string

David Melville

http://www.w3.org/2001/XMLSchema#string

Fu Liang Ng

http://www.w3.org/2001/XMLSchema#string

Maksym I Harhun

http://www.w3.org/2001/XMLSchema#string

Marcus Reddy

http://www.w3.org/2001/XMLSchema#string

Shuk Yin Yeung

http://www.w3.org/2001/XMLSchema#string

Teck K Khong

http://www.w3.org/2001/XMLSchema#string

P2860

Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel

Pulmonary vasoconstrictor action of KCNQ potassium channel blockers.

A new mathematical model for relative quantification in real-time RT-PCR

Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine

Localization of KCNQ5 in the normal and epileptic human temporal neocortex and hippocampal formation

Dose-related analgesic effects of flupirtine.

Molecular basis for differential sensitivity of KCNQ and I(Ks) channels to the cognitive enhancer XE991.

Neuronal KCNQ potassium channels: physiology and role in disease.

Retigabine: chemical synthesis to clinical application.

Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures.

P304

42-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1476-5381.2010.01027.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

162

http://www.w3.org/2001/XMLSchema#string

P50

Iain A Greenwood

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46272299

http://www.w3.org/2001/XMLSchema#string

P698

20840535

http://www.w3.org/2001/XMLSchema#string

P932

3012405

http://www.w3.org/2001/XMLSchema#string